Bristol-Myers Squibb, the multinational pharmaceutical company headquartered in New York City, has named Pamela Fisher as the company’s new chief diversity and inclusion officer. Fisher previously served as the head of diversity, equity & inclusion global strategy and partnerships at another pharmaceutical giant, Johnson & Johnson (a Fair360, formerly DiversityInc Hall of Fame Company), since 2017.
Linda Lindner of ROI-NJ reported that “Fisher will drive BMS’ Global Diversity & Inclusion business strategy, including advancing the company’s five core diversity commitments. She will be a member of CEO Giovanni Caforio’s leadership team.”
In a statement, Caforio said, “as a science leader, we have seen firsthand how diversity of thought, experience and background drives innovation that transforms patients’ lives. Pam is joining our company as we make progress on our commitment to increasing health equity, further strengthen our diversity and shape our culture of inclusion.”
